Recall status clarification
Levothyroxine recall 2026
FDA distinguishes approved synthetic levothyroxine from unapproved animal-derived thyroid products. This page checks recent enforcement records and explains that distinction.
Searches for a levothyroxine recall are being driven in part by an FDA action concerning unapproved animal-derived thyroid medications, not a blanket recall of synthetic levothyroxine.
- FDA publish date
- March 11, 2026
- Company
- U.S. Food and Drug Administration
- Product
- Synthetic levothyroxine products
- Last checked
- September 23, 2026
- NDC / identifier
- No specific identifier listed in this announcement
- Affected lot(s)
- No specific lot listed for this clarification
What the FDA announcement says
Searches for a levothyroxine recall are being driven in part by an FDA action concerning unapproved animal-derived thyroid medications, not a blanket recall of synthetic levothyroxine.
Read the original FDA actions addressing unapproved thyroid medications →
What to check on the package
- Confirm the exact product and brand name.
- Compare the manufacturer or distributor.
- Match the NDC or product identifier.
- Match the lot or code exactly; a drug name alone is not enough.
What to do
Do not stop or change a prescribed medication based only on this page. Contact a pharmacist, prescriber, or the recalling company for instructions specific to your product.
Related FDA enforcement records
62 matching records appear in the current 24-month openFDA snapshot. Use the search tool to compare the exact manufacturer, NDC, and lot.
Search all records for Levothyroxine →
Source and limitations
This server-rendered page summarizes an FDA source and the openFDA enforcement snapshot last checked on September 23, 2026. It is not an FDA service and does not provide individual medical advice.